Ngā hua rapu - Colombe Chappey
- E whakaatu ana i te 1 - 20 hua o te 20
-
1
Improving lopinavir genotype algorithm through phenotype correlations mā Neil Parkin, Colombe Chappey, Christos J. Petropoulos
I whakaputaina 2003Artigo -
2
-
3
-
4
A web-based genotyping resource for viral sequences mā Mikhail Rozanov, Uwe Plikat, Colombe Chappey, Andrey Vasilyevich Kochergin, Tatiana Tatusova
I whakaputaina 2004Artigo -
5
-
6
-
7
Simian T-Cell Lymphotropic Virus Type 1 from <i>Mandrillus sphinx</i> as a Simian Counterpart of Human T-Cell Lymphotropic Virus Type 1 Subtype D mā Renaud Mahieux, Colombe Chappey, Marie‐Claude Georges‐Courbot, Guy Dubreuil, Philippe Mauclère, Alain Georges, Antoine Gessain
I whakaputaina 1998Artigo -
8
-
9
Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B mā Simon D. W. Frost, Yang Liu, Sergei L. Kosakovsky Pond, Colombe Chappey, Terri Wrin, Christos J. Petropoulos, Susan J. Little, Douglas D. Richman
I whakaputaina 2005Artigo -
10
Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism mā Jeannette M. Whitcomb, Wei Huang, Signe Fransen, Kay Limoli, Jonathan Toma, Terri Wrin, Colombe Chappey, Linda D. B. Kiss, Ellen E. Paxinos, Christos J. Petropoulos
I whakaputaina 2006Artigo -
11
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys mā Michaela Müller‐Trutwin, Nitin K. Saksena, Eric Nerrienet, Colombe Chappey, Vincent Hervé, Jean Paul Durand, P Legal-Campodonico, Marie-Claude Lang, J.P. Digoutte, A.J. Georges
I whakaputaina 1993Artigo -
12
An Evolutionary Model-Based Algorithm for Accurate Phylogenetic Breakpoint Mapping and Subtype Prediction in HIV-1 mā Sergei L. Kosakovsky Pond, David Posada, Eric Stawiski, Colombe Chappey, Art F. Y. Poon, G. Hughes, Esther Fearnhill, Mike B. Gravenor, Andrew Brown, Simon D. W. Frost
I whakaputaina 2009Artigo -
13
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies mā James Μ. Binley, Terri Wrin, Bette Korber, Michael B. Zwick, Meng Wang, Colombe Chappey, Gabriela Stiegler, Renate Kunert, Susan Zolla‐Pazner, Hermann Katinger, Christos J. Petropoulos, Dennis R. Burton
I whakaputaina 2004Artigo -
14
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in... mā Renaud Mahieux, Fera Ibrahim, Philippe Mauclère, Vincent Hervé, Philippe Michel, Fredj Tekaia, Colombe Chappey, B. Garin, Elna van der Ryst, Bernard Guillemain, Éric Ledru, Éric Delaporte, Guy de Thé, Antoine Gessain
I whakaputaina 1997Artigo -
15
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection mā Simon D. W. Frost, Terri Wrin, Davey M. Smith, Sergei L. Kosakovsky Pond, Yang Liu, Ellen E. Paxinos, Colombe Chappey, Justin Galovich, Jeff Beauchaine, Christos J. Petropoulos, Susan J. Little, Douglas D. Richman
I whakaputaina 2005Artigo -
16
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus mā Rika Draenert, Todd M. Allen, Yang Liu, Terri Wrin, Colombe Chappey, Cori L. Verrill, Guillem Sirera, Robert L. Eldridge, Matthew Lahaie, Lidia Ruíz, Bonaventura Clotet, Christos J. Petropoulos, Bruce D. Walker, Javier Martínez‐Picado
I whakaputaina 2006Artigo -
17
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline <i>BRCA1/2</i> Mutations (ABRAZO) mā Nicholas C. Turner, Melinda L. Telli, Hope S. Rugo, Audrey Mailliez, Johannes Ettl, Eva‐Maria Grischke, Lida A. Mina, Judith Balmañà, Peter A. Fasching, Sara A. Hurvitz, Andrew Wardley, Colombe Chappey, Alison L. Hannah, Mark E. Robson
I whakaputaina 2018Artigo -
18
A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism mā Monique Nijhuis, Noortje M. van Maarseveen, Stéphane Lastère, P Schipper, Eoin Coakley, Bärbel Glass, Mirka Rovenska, Dorien de Jong, Colombe Chappey, Irma W Goedegebuure, Gabrielle Heilek‐Snyder, Dominic Dulude, Nick Cammack, Léa Brakier‐Gingras, Jan Konvalinka, Neil Parkin, Hans‐Georg Kräusslich, Françoise Brun‐Vézinet, Charles A. Boucher
I whakaputaina 2007Artigo -
19
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors mā Timothy A. Yap, Aditya Bardia, Michael Dvorkin, Matthew D. Galsky, J. Thaddeus Beck, David R. Wise, O. B. Karyakin, Gábor Rubovszky, Nikolay Kislov, Kristoffer Staal Rohrberg, Anil A. Joy, Melinda L. Telli, Alison M. Schram, Umberto Conte, Colombe Chappey, Ross Stewart, Daria Stypinski, Elisabete Michelon, Rossano Cesari, Panagiotis A. Konstantinopoulos
I whakaputaina 2022Carta -
20
Avelumab Plus Talazoparib in Patients With <i>BRCA1/2</i>- or <i>ATM</i>-Altered Advanced Solid Tumors mā Alison M. Schram, Nicoletta Colombo, Edward Arrowsmith, Vivek Narayan, Kan Yonemori, Giovanni Scambia, Amelia Zelnak, Todd M. Bauer, Ning Jin, Susanna V. Ulahannan, Marco Colleoni, Philippe Aftimos, Mark T.A. Donoghue, Ezra Rosen, Vasilisa A. Rudneva, Melinda L. Telli, Susan M. Domchek, Matthew D. Galsky, Margaret Hoyle, Colombe Chappey, Ross Stewart, John A. Blake-Haskins, Timothy A. Yap
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Virology
Genetics
Virus
Gene
Medicine
Genotype
Antiretroviral therapy
Immunology
Viral disease
Viral load
Antibody
Biochemistry
Cancer
Computational biology
Drug resistance
Enzyme
Genome
HIV-1 protease
Human immunodeficiency virus (HIV)
Internal medicine
Mutation
Neutralization
Oncology
Phylogenetic tree
Protease
Viral replication
Antigen
Avelumab
Breast cancer